Article info

1-year cost-utility analysis of prostate artery embolization (PAE) versus transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH)

Authors

  1. Correspondence to Dr Sachin Modi; sachin.modi{at}uhs.nhs.uk
View Full Text

Citation

Patel N, Yung N, Vigneswaran G, et al
1-year cost-utility analysis of prostate artery embolization (PAE) versus transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH)

Publication history

  • Received October 25, 2020
  • Accepted October 1, 2021
  • First published November 11, 2021.
Online issue publication 
November 11, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.